“a promising medium‐term follow‐up of pediatric sclerosing cholangitis: mild phenotype or early diagnosis?”
ConclusionsIn our early‐diagnosed population, the 9‐year survival with native liver was better than what reported in other studies. About 15% of patients developed liver‐related disease complications, less than previous reports. Long‐term course of SC was negatively influenced by the presence of autoimmune features but not by concomitant IBD.
Source: Hepatology Research - Category: Internal Medicine Authors: F. Ferrari, G. Ranucci, M. Aloi, L. Della Volpe, F. Viola, E. Miele, S. Cucchiara, R. Iorio Tags: Original Article Source Type: research
More News: Autoimmune Disease | Children | Cirrhosis | Hepatitis | Inflammatory Bowel Disease | Internal Medicine | Liver | Liver Disease | Liver Transplant | Pediatrics | Study | Transplants | Urology & Nephrology